Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale
The DOI matches its Crossref record.
Abstract
Relatively little research has focused on the relationship between functional remission and symptomatic remission in mood and anxiety disorders. This study investigates the relationship and synchrony between symptomatic and functional remission in outpatients with major depressive disorder (MDD) and generalized anxiety disorder (GAD). Using data from three MDD (N=1419) and four GAD (N=1847) randomized, placebo-controlled duloxetine studies, we calculated the percentages of patients meeting symptomatic, functional, and combined functional-symptomatic remission criteria for each disorder. We also calculated mean depression [17-item Hamilton depression rating scale (HAMD₁₇), Montgomery-Asberg depression rating scale] scores and mean anxiety (Hamilton anxiety rating scale) scores for patients meeting Sheehan disability scale (SDS) functional remission and the mean SDS scores for patients with symptomatic remission. Among the patients with MDD, 38% achieved symptomatic remission (HAMD₁₇ ≤ 7), 32% achieved functional remission (SDS ≤ 6), and 23% achieved combined functional-symptomatic remission. Mean HAMD₁₇ and Montgomery-Asberg depression rating scale scores for patients with functional remission were approximately 6. Mean SDS total scores for patients with symptomatic remission were 7.1 (patients with HAMD₁₇ ≤ 7) and 8.6 (patients with Montgomery-Asberg depression rating scale ≤ 10). Among the patients with GAD, 30% achieved symptomatic remission (Hamilton anxiety rating scale ≤ 7), 45% achieved functional remission (SDS ≤ 6), and 25% achieved combined symptomatic-functional remission. The mean Hamilton anxiety rating scale score in GAD was approximately 8 for patients with functional remission and the mean SDS total score was approximately 4 in patients with symptomatic remission. The study shows that functional remission does not always move in tandem with symptom remission and provides useful anchor points or rules of thumb for evaluating symptomatic and functional remission in MDD and GAD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MDD patients have lower remission rates due to cognitive impairment.5”
Citations
Cites
Still being checked.
Cited by
Sforzini, L., Worrell, C., Kose, M., Anderson, I. M., Aouizerate, B., Arolt, V., Bauer, M., Baune, B. T., Blier, P., Cleare, A. J., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01381-x · Cited by 214
“INTRODUCTION Many medications have proven efficacy in major depressive disorder (MDD) [1, 2], but frequently and even with multiple medication exposures, they fail to improve MDD symptoms [3–7]; one third of individuals do not achieve full symptomatic remission [3], and even fewer meet criteria for both symptomatic an…”
BackgroundRestoring function in major depressive disorder: A systematic review
Sheehan, D. V., Nakagome, K., Asami, Y., Pappadopulos, E. A., & Boucher, M. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.029 · Cited by 182
Self-citationOluboka, O. J., Katzman, M. A., Habert, J., McIntosh, D., MacQueen, G. M., Milev, R. V., McIntyre, R. S., & Blier, P. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx081 · Cited by 104
Lam, R., Lamy, F.-X., Danchenko, N., Yarlas, A., White, M. K., Rive, B., & Saragoussi, D. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s175188 · Cited by 101
Dunn, B. D., German, R. E., Khazanov, G., Xu, C., Hollon, S. D., & DeRubeis, R. J. (2020) · Clinical Psychological Science · doi:10.1177/2167702619863427 · Cited by 92
Sambunaris, A., Bose, A., Gommoll, C. P., Chen, C., Greenberg, W. M., & Sheehan, D. V. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000060 · Cited by 90
Self-citationZhu, C., Zhang, Y., Wang, T., Lin, Y., Yu, J., Xia, Q., Zhu, P., & Zhu, D. (2020) · Brain and Behavior · doi:10.1002/brb3.1760 · Cited by 104
DiMauro, J., Domingues, J., Fernandez, G., & Tolin, D. F. (2012) · Behaviour Research and Therapy · doi:10.1016/j.brat.2012.10.003 · Cited by 111
Dunn, B. D., Widnall, E., Reed, N., Owens, C., Campbell, J., & Kuyken, W. (2019) · Behaviour Research and Therapy · doi:10.1016/j.brat.2019.103418 · Cited by 70
Bakish, D., Bose, A., Gommoll, C., Chen, C., Nunez, R., Greenberg, W. M., Liebowitz, M., & Khan, A. (2014) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.130040 · Cited by 70
Beevers, C. G., Pearson, R., Hoffman, J. S., Foulser, A. A., Shumake, J., & Meyer, B. (2017) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000171 · Cited by 69
Reward systems and cognitions in Major Depressive Disorder
Cléry-Melin, M.-L., Jollant, F., & Gorwood, P. A. P. M. (2018) · CNS Spectrums · doi:10.1017/s1092852918001335 · Cited by 83
Calabrese, J. R., Fava, M., Garibaldi, G. M., Grunze, H., Krystal, A. D., LAUGHREN, T. P., Macfadden, W., Marin, R. S., Nierenberg, A. A., & Tohen, M. F. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.06.056 · Cited by 79
Sickness behaviour and depression: An updated model of peripheral-central immunity interactions
Turkheimer, F., Veronese, M., Mondelli, V., Cash, D., & Pariante, C. M. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.031 · Cited by 72
Cha, D. S., Carmona, N. E., Subramaniapillai, M., Mansur, R. B., Lee, Y. L., Lee, J. H., Lee, J., Rosenblat, J. D., Shekotikhina, M., Park, C., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.036 · Cited by 64
for the Study 3362 Investigators, Liebowitz, M. R., Tourian, K. A., Hwang, E., & Mele, L. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-94 · Cited by 49
Deardorff, W. J., & Grossberg, G. T. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.960842 · Cited by 49
Xiao, L., Feng, L., Zhu, X., Feng, Y., Wu, W., Ungvari, G. S., Ng, C. H., Xiang, Y., & Wang, G. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.01.020 · Cited by 55
Christensen, M. C., Loft, H., & McIntyre, R. S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.081 · Cited by 46
Levomilnacipran for the treatment of major depressive disorder: a review
Asnis, G. M., & Henderson, M. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s54710 · Cited by 46
Porcu, M., Urbano, M. R., Verri, W. A., Jr., Barbosa, D. S., Baracat, M. M., Vargas, H. O., Machado, R. C. B. R., Pescim, R. R., & Nunes, S. O. V. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.02.056 · Cited by 49
The effect of vortioxetine on overall patient functioning in patients with major depressive disorder
Florea, I., Loft, H., Danchenko, N., Rive, B., Brignone, M., Merikle, E., Jacobsen, P. L., & Sheehan, D. V. (2017) · Brain and Behavior · doi:10.1002/brb3.622 · Cited by 40
Self-citationMattingly, G. W., Ren, H., Christensen, M. C., Katzman, M. A., Polosan, M., Simonsen, K., & Hammer-Helmich, L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.824831 · Cited by 47
Iancu, S. C., Batelaan, N. M., Zweekhorst, M. B. M., Bunders, J. F. G., Veltman, D. J., Penninx, B. W. J. H., & van Balkom, A. J. L. M. (2014) · Psychological Medicine · doi:10.1017/s0033291713001050 · Cited by 38
Novick, D., Montgomery, W. S., Vorstenbosch, E., Moneta, M. V., Dueñas, H., & Haro, J. M. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s138750 · Cited by 47
Associations between cognitive impairment and quality of life in euthymic bipolar patients
Toyoshima, K., Kako, Y., Toyomaki, A., Shimizu, Y., Tanaka, T., Nakagawa, S., Inoue, T., Martínez‐Arán, A., Vieta, E., & Kusumi, I. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.11.061 · Cited by 42
Self Efficacy in Depression: Bridging the Gap Between Competence and Real World Functioning
Milanovic, M., Ayukawa, E., Usyatynsky, A., Holshausen, K., & Bowie, C. R. (2018) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000804 · Cited by 41
Sheehan, D. V., Mancini, M., Wang, J., Berggren, L., Cao, H., Dueñas, H., & Li, Y. (2015) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2500 · Cited by 30
Self-citationStein, D. J., Kazdin, A. E., Ruscio, A. M., Chiu, W. T., Sampson, N. A., Ziobrowski, H. N., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Altwaijri, Y., et al. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03363-3 · Cited by 31
“Yet, symptom reduction does not necessarily equate with functional improvement, quality of life, or feelings on the part of the patient that they have been helped [11, 12].”
BackgroundRapastinel - an investigational NMDA-R modulator for major depressive disorder: evidence to date
Ragguett, R.-M., Rong, C., Kratiuk, K., & McIntyre, R. S. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1559295 · Cited by 30
Toyoshima, K., Inoue, T., Masuya, J., Ichiki, M., Fujimura, Y., & Kusumi, I. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s218382 · Cited by 31
Correll, C. U., Cortese, S., Solmi, M., Boldrini, T., Demyttenaere, K., Domschke, K., Fusar‐Poli, P., Gorwood, P. A. P. M., Harvey, P. D., Keefe, R. S. E., et al. (2025) · World Psychiatry · doi:10.1002/wps.21338 · Cited by 39
Cléry-Melin, M.-L., & Gorwood, P. A. P. M. (2016) · Depression and Anxiety · doi:10.1002/da.22575 · Cited by 27
Zhao, N., Wang, X., Wu, W., Hu, Y., Niu, Y., Wang, X., Gao, C., Zhang, N., Fang, Y., Jizhong, H., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.05.021 · Cited by 26
Sex differences in the mediators of functional disability in Major Depressive Disorder
Carmona, N. E., Subramaniapillai, M., Mansur, R. B., Cha, D. S., Lee, Y., Fus, D., & McIntyre, R. S. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.09.025 · Cited by 22
Sambunaris, A., Gommoll, C., Chen, C., & Greenberg, W. M. (2014) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000033 · Cited by 23
Yrondi, A., Javelot, H., Nobile, B., Boudieu, L., Aouizerate, B., Llorca, P., Charpeaud, T., Bennabi, D., Lefrere, A., & Samalin, L. (2024) · L Encéphale · doi:10.1016/j.encep.2023.11.029 · Cited by 26
Xiao, L., Zhou, J., Feng, Y., Zhu, X., Wu, W., Hu, Y., Niu, Y., Hu, J., Wang, X., Gao, C., et al. (2019) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2019.101843 · Cited by 22
Functioning, Disability, and Social Adaptation Six Months After Burn Injury
Palmu, R., Partonen, T., Suominen, K. H., Vuola, J., & Isometsä, E. T. (2015) · Journal of Burn Care & Research · doi:10.1097/bcr.0000000000000258 · Cited by 22
Harvey, P. D., Jacobson, W., Zhong, W., Nomikos, G. G., Christensen, M. C., Olsen, C. K., & Merikle, E. P. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.014 · Cited by 20
Papalexi, E., Galanopoulos, A., Roukas, D., Argyropoulos, I., Michopoulos, I., Douzenis, A., Gkolia, I., Fotiadis, P., Kontis, D., & Zervas, I. M. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.009 · Cited by 20
Nordbrandt, M. S., Carlsson, J. M., Lindberg, L. G., Sandahl, H., & Mortensen, E. L. (2015) · Trials · doi:10.1186/s13063-015-0974-9 · Cited by 22
Schwarz, R., Munkholm, K., Christensen, M. S., Kessing, L. V., & Vinberg, M. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.07.054 · Cited by 17
Montgomery, S., Mansuy, L., Ruth, A., Li, D., & Gommoll, C. (2013) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000009 · Cited by 17
Lack of association between unipolar or bipolar depression and serum aquaporin-4 autoantibodies
Gur, S., Taler, M., Bormant, G., Blattberg, D., Nitzan, U., Vaknin‐Dembinsky, A., Brill, L., Krivoy, A., Weizman, A., & Hochman, E. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.001 · Cited by 18
Antidepressants overuse in primary care: Prescription trends between 2010 and 2019 in Catalonia
Anmella, G., Sanabra, M., Primé‐Tous, M., Segú, X., Solanes, A., Ruíz, V., Morilla, I., Fontanet, A. A., Sant, E., Murgui, S., et al. (2022) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2022.12.001 · Cited by 21
Montoya, A., Lebrec, J., Keane, K. M., Fregenal, I., Ciudad, A., Moríñigo, Á., Agüera-Ortíz, L., Romera, I., Gilaberte, I., & Zimmerman, M. A. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1067-3 · Cited by 15
Durgam, S., Gommoll, C., Migliore, R., Chen, C., Chang, C.-T., Aguirre, M., & Thase, M. E. (2018) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000236 · Cited by 16
Zeljic, K., Zhang, Y., Qiu, X., Chen, X., Gong, H., Jin, H., Zhang, C., & Storch, E. A. (2020) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.34.1.58 · Cited by 15
Gorwood, P. A. P. M., Demyttenare, K., Vaïva, G., Corruble, E., Llorca, P., Bayle, F., & Courtet, P. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.019 · Cited by 17
Papalexi, E., Galanopoulos, A., Kontis, D., Markopoulou, M., Balta, G., Karavelas, E., Panagiotidis, P., Vlachos, T., & Ettrup, A. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04109-5 · Cited by 16
Tanarsuwongkul, S., Liu, J., Spaulding, M., Perea-Schmittle, K., Lohman, M. C., & Wang, Q. (2025) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796024000866 · Cited by 19
Hernandez, M. E. H., Michalak, E. E., Choudhury, N., Hewko, M. D., Torres, I. J., Menon, M., Lam, R. W. M., & Chakrabarty, T. (2023) · JMIR Serious Games · doi:10.2196/43904 · Cited by 14
Sforzini, L. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100331 · Cited by 15
Sheehan, D. V., Svedsäter, H., Locklear, J. C., & Eriksson, H. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.07.037 · Cited by 17
Self-citationEffects of desvenlafaxine versus placebo on MDD symptom clusters: A pooled analysis
Katzman, M. A., Wang, X., Wajsbrot, D., & Boucher, M. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119896066 · Cited by 14
Molero, P., Ibáñez, Á., de Diego-Adeliño, J., Ramos‐Quiroga, J. A., Dorado, M. G., Rengel, P. M. L., & Sáiz, P. A. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03149-z · Cited by 15
Filippis, S. D., Pugliese, A., Christensen, M. C., Rosso, G., Nicola, M. D., Simonsen, K., & Ren, H. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s375294 · Cited by 13
Structural equation modeling approach to explore the influence of childhood maltreatment in adults
Toyoshima, K., Inoue, T., Masuya, J., Fujimura, Y., Higashi, S., Tanabe, H., & Kusumi, I. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239820 · Cited by 14
Congio, A. C., Urbano, M. R., Soares, M. R. Z., & Nunes, S. O. V. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.07.052 · Cited by 14
Typology of patients with fibromyalgia: cluster analysis of duloxetine study patients
Lipkovich, I. A., Choy, E., Wambeke, P. V., Deberdt, W. G., & Sagman, D. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-450 · Cited by 13
Cross, S. P. M., Karin, E., Asrianti, L., Walker, J., Staples, L., Bisby, M. A., Nielssen, O. B., Kayrouz, R., Fisher, A. C., Dear, B. F., et al. (2023) · Internet Interventions · doi:10.1016/j.invent.2023.100603 · Cited by 13
Tamura, J. K., Harangi, D., Rodrigues, N. B., Mansur, R. B., Subramaniapillai, M., Johnson, D. E., Rosenblat, J. D., Lee, Y. L., Vincenzo, J. D. D., Ho, R., et al. (2024) · CNS Spectrums · doi:10.1017/s1092852924002293 · Cited by 13
Bottaccioli, A. G., Bologna, M., & Bottaccioli, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062759 · Cited by 19
Zhou, J., Zhu, T., Zhu, X., Galling, B., & Xiao, L. (2022) · BMC Psychiatry · doi:10.1186/s12888-021-03411-y · Cited by 11
Yassin, A., Al-Mistarehi, A.-H. W., Qarqash, A., Soudah, O., Karasneh, R. A., Al-Azzam, S. I., Khasawneh, A. G., El‐Salem, K., Kheirallah, K. A., & Khassawneh, B. Y. (2022) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/17450179-v18-e2206200 · Cited by 11
Wang, G., You, X., Wang, X., Xu, X., Bai, L., Xie, J. M., Yao, Z., Yi, Q., Ma, J., Wang, J., et al. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s164673 · Cited by 12
Toyoshima, K., Inoue, T., Masuya, J., Fujimura, Y., Higashi, S., & Kusumi, I. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s256647 · Cited by 11
Roberge, P., Fournier, L., Brouillet, H., Hudon, C., Houle, J., Provencher, M. D., & Lévesque, J. (2013) · Implementation Science · doi:10.1186/1748-5908-8-26 · Cited by 13
Zhang, Y., Huang, G., Yang, S., Liang, W., Zhang, L., & Wang, C. (2015) · Asia-Pacific Psychiatry · doi:10.1111/appy.12203 · Cited by 11
Association of clinical features and biomarkers with treatment-resistant depression
Congio, A. C., Norcia, M., Urbano, M. R., Verri, W. A., Jr., & Nunes, S. O. V. (2020) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2020.02.004 · Cited by 12
Hewko, M. D., Shaigetz, V. G., Smith, M. S. D., Kohlenberg, E. M., Ahmadi, P., Hernandez, M. E. H., Proulx, C., Cabral, A., Segado, M., Chakrabarty, T., et al. (2025) · JMIR Serious Games · doi:10.2196/59514 · Cited by 10
Zhou, J., Xu, J., Feng, Z., Liu, R., Xiao, L., Li, R., Li, X., Zhang, X., Liu, J., Feng, Y., et al. (2025) · Psychological Medicine · doi:10.1017/s0033291725001011 · Cited by 11
Mosca, D., Zhang, M., Prieto, R., & Boucher, M. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000674 · Cited by 10
Huang, J., Wang, Y., Chen, J., Zhang, Y., Yuan, Z., Li, Y., Haro, J. M., Moneta, M. V., Novick, D., & Fang, Y. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s159800 · Cited by 9
Lundqvist, J., Lindberg, M. S., Brattmyr, M., Havnen, A., Hjemdal, O., & Solem, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311420 · Cited by 10
Rodrigues, N. B., McIntyre, R. S., Lipsitz, O., Lee, Y. L., Subramaniapillai, M., Kratiuk, K., Majeed, A., Nasri, F., Gill, H., Mansur, R. B., et al. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113860 · Cited by 9
Sheehan, D. V., Gasior, M., McElroy, S. L., Radewonuk, J., Herman, B. K., & Hudson, J. I. (2018) · Europe PMC (PubMed Central) · Cited by 8
Self-citationSerowik, K. L., Roemer, L., Suvak, M., Liverant, G., & Orsillo, S. M. (2020) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2020.1765858 · Cited by 7
Development of the Global Disability Scale (Glo.Di.S): preliminary results
Fountoulakis, K. Ν., Lekka, I., Kouidi, E. J., Chouvarda, I., Deligiannis, A. P., & Maglaveras, N. (2012) · Annals of General Psychiatry · doi:10.1186/1744-859x-11-14 · Cited by 8
Wang, G., Zhao, K., Reynaud-Mougin, C., Loft, H., Ren, H., Eriksen, H. F., & Ettrup, A. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1723072 · Cited by 8
Residual hypersomnia in unipolar and bipolar depression: A systematic review
Kwaśna, J., Kwaśny, A., Wilkowska, A., Bychowski, M., & Cubała, W. J. (2024) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2024.2429429 · Cited by 6
Polosan, M., Rabbani, M., Christensen, M. C., Simonsen, K., & Ren, H. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s374635 · Cited by 6
Dimensions and Predictors of Personal Recovery in Major Depression
Luciano, M., Carmassi, C., & Albert, U. (2022) · Comprehensive approach to psychiatry · doi:10.1007/978-3-030-98301-7_13 · Cited by 8
The dose-response relationship of vortioxetine on major depressive disorder: an umbrella review
Wang, P., Wang, W., Liu, Y., Li, W., Hu, J., Su, Y., Li, J., Li, N., & Si, T. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116118 · Cited by 6
Basile, V. T., Newton-John, T. R. O., McDonald, S., & Wootton, B. M. (2024) · British Journal of Clinical Psychology · doi:10.1111/bjc.12482 · Cited by 10
Tellone, V., Markovič, O., Strashimirova, M., Sani, G., Lenderking, W. R., Margolis, M. K., Fallone, R., Quarchioni, E., Cattaneo, A., & Comandini, A. (2024) · Brain and Behavior · doi:10.1002/brb3.3580 · Cited by 6
Ameringen, M. V., Simpson, W. S., Patterson, B. A., & Turna, J. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.10.031 · Cited by 6
Zhou, R., Chen, J., Zhao, G., Wang, Z., Peng, D., Xia, W., Mao, R., Xu, J., Wang, F., Zhang, C., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110337 · Cited by 7
The effect of the time to remission on residual symptoms and functioning among depressive patients
Zhu, X., Mayes, T. L., Qi, N., Feng, L., Feng, Y., Wu, W., Hu, Y., Xiao, L., & Wang, G. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.10.006 · Cited by 6
Aydın, E. F., & Laçin, T. K. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1444583 · Cited by 6
Neugebauer, J., & Tóthová, V. (2019) · Kontakt · doi:10.32725/kont.2019.032 · Cited by 4
Yee, K. S. Y., Pokrzywinski, R. M., Hareendran, A., Shaffer, S., & Sheehan, D. V. (2020) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1849 · Cited by 7
Self-citationYe, X., Xu, P., Jiao, J., Zhao, H., Jin, K., Zhang, S., Pan, F., Chen, J., Jiang, H., Hu, J., et al. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s491768 · Cited by 3
Kato, M., Kikuchi, T., Watanabe, K., Sumiyoshi, T., Moriguchi, Y., Åström, D., & Christensen, M. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s428443 · Cited by 3
“36 Similarly, we observed a direct negative correlation of emotional blunting on ODQ with cognitive performance as assessed by DSST.”
MethodOluboka, O. J., Habert, J., Khullar, A., Robinson, D. J., Katzman, M. A., Klassen, L. J., Soares, C., Chokka, P. R., Oakander, M. A., McIntyre, R. S., et al. (2025) · CNS Spectrums · doi:10.1017/s1092852925000276 · Cited by 3
The Impact of Two Brief Web-Based Psychological Interventions on Functional Outcomes
Morabito, D. M., Mathes, B. M., & Schmidt, N. B. (2020) · Cognitive Therapy and Research · doi:10.1007/s10608-020-10144-x · Cited by 3
Watanabe, K., Thase, M. E., Kikuchi, T., Tsuboi, T., Asami, Y., Pappadopulos, E. A., Zhang, M., Boucher, M., & Kornstein, S. G. (2017) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000183 · Cited by 3
Soares, C. N., Wajsbrot, D., & Boucher, M. (2019) · CNS Spectrums · doi:10.1017/s1092852919000828 · Cited by 3
Møeller, S. B., Larsen, P. V., Austin, S. F., Slade, M., Arendt, I. T. P., Kring, L. D., & Simonsen, S. (2025) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-025-02948-7 · Cited by 2
Metadata
- Authors
- Sheehan, D. V., Harnett-Sheehan, K., Spann, M. E., Thompson, H. F., & Prakash, A.
- Affiliations
- University of South Florida (US)
- Alcon (United States) (US)
- Eli Lilly (United States) (US)
- Corresponding author
- Prakash, Apurva
- ORCID
- Sheehan, David V.
- Venue
- International Clinical Psychopharmacology
- Published
- 2011-03
- Volume
- 26
- Issue
- 2
- Pages
- 75-83
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2025491005
- Cited by
- 124
- References
- 0
- Citations by year
- 2026: 3 · 2025: 16 · 2024: 10 · 2023: 7 · 2022: 14 · 2021: 9 · 2020: 11 · 2019: 7 · 2018: 11 · 2017: 12 · 2016: 2 · 2015: 8 · 2014: 5 · 2013: 7 · 2012: 2
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Mental Health Research Topics
- Keywords
- functional remission, symptom remission, major depressive disorder, generalized anxiety disorder, Sheehan Disability Scale, duloxetine, outpatients, remission assessment, mood and anxiety disorders, Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale
- MeSH terms
- Duloxetine Hydrochloride, Antidepressive Agents, Anxiety Disorders, Depression, Major Depressive Disorder, Double-Blind Method, Humans, Outpatients, Placebos, Psychiatric Status Rating Scales, Psychometrics, Thiophenes, Time Factors, Comorbidity, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.